About: Neurizon Therapeutics Limited, a clinical stage biotechnology company, engages in the development of treatments for neurodegenerative diseases in Australia. Its lead candidate is NUZ-001, a small molecule drug designed to support cellular protein homeostasis which is evaluated in Regimen I of the Phase 2/3 HEALEY ALS platform trial for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.09 (-2.27%)
NUZ ASX Neurizon Therapeutics Ltd
Neurizon Therapeutics Ltd share price
Atividade de preço de NUZ
Último preço
$ 0,090
Variação (24h)
-0,00 AUD (2,27%)
Volume
436.06K
Volume (média 4 sem.)
-
Abertura
$ 0,09
Variação do dia
$ 0,09 - $ 0,09
Fechamento anterior
$ 0,09
Último negócio
27 Oct, 5:10 am GMT+0
Atrasado
27 Oct, 5:10 am GMT+0
NUZ price performance
Atrasado
27 Oct, 5:10 am GMT+0
quote.marketSignals